Total Payments
$2,351
2024 Payments
$416.94
Companies
22
Transactions
84
Medicare Patients
2,770
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$2,351 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,351 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $593.48 | 26 | $0 (2024) |
| Celgene Corporation | $349.72 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $223.58 | 7 | $0 (2024) |
| Incyte Corporation | $184.99 | 9 | $0 (2023) |
| Lilly USA, LLC | $155.30 | 5 | $0 (2024) |
| Amgen Inc. | $139.08 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $100.24 | 5 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $77.78 | 4 | $0 (2024) |
| UCB, Inc. | $73.42 | 4 | $0 (2024) |
| Galderma Laboratories, L.P. | $64.49 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $416.94 | 14 | Janssen Biotech, Inc. ($152.35) |
| 2023 | $374.21 | 16 | AbbVie Inc. ($139.56) |
| 2022 | $506.30 | 19 | ABBVIE INC. ($138.32) |
| 2021 | $313.51 | 15 | AbbVie Inc. ($139.87) |
| 2020 | $89.74 | 5 | AbbVie Inc. ($41.03) |
| 2019 | $347.86 | 9 | Celgene Corporation ($131.72) |
| 2018 | $287.70 | 5 | Celgene Corporation ($218.00) |
| 2017 | $14.95 | 1 | LEO Pharma Inc. ($14.95) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Advanced Oxygen Therapy Inc. | Topical Oxygen Chamber for extremities (Device) | Food and Beverage | Cash or cash equivalent | $8.17 | General |
| Category: Topical Wound Oxygen | ||||||
| 06/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Immunology | ||||||
| 06/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DERMATOLOGY | ||||||
| 04/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: Immunology | ||||||
| 04/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Dermatology | ||||||
| 04/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Immunology | ||||||
| 03/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Immunology | ||||||
| 02/20/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Immunology | ||||||
| 02/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $92.20 | General |
| Category: Immunology | ||||||
| 01/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 08/30/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $98.97 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Dermatology | ||||||
| 08/04/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.20 | General |
| Category: Dermatology | ||||||
| 06/30/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 05/26/2023 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: DERMATOLOGY | ||||||
| 05/17/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.81 | General |
| Category: Dermatology | ||||||
| 05/02/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Immunology | ||||||
| 04/13/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.51 | General |
| Category: Dermatology | ||||||
| 04/06/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 845 | 978 | $983,735 | $332,132 |
| 2022 | 14 | 739 | 880 | $879,348 | $296,036 |
| 2021 | 16 | 794 | 964 | $943,901 | $319,033 |
| 2020 | 9 | 392 | 457 | $484,386 | $149,652 |
Total Patients
2,770
Total Services
3,279
Medicare Billing
$1.1M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 304 | 374 | $497,420 | $188,480 | 37.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 108 | 130 | $162,240 | $60,822 | 37.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 62 | 82 | $66,174 | $26,682 | 40.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 99 | 111 | $105,228 | $21,502 | 20.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 43 | 45 | $38,610 | $9,265 | 24.0% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 44 | 44 | $34,364 | $6,657 | 19.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 35 | 36 | $21,888 | $4,694 | 21.4% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 19 | 19 | $16,150 | $3,193 | 19.8% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $10,426 | $2,837 | 27.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 18 | 18 | $11,070 | $2,211 | 20.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 45 | $4,950 | $1,771 | 35.8% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 11 | 11 | $7,315 | $1,722 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 28 | $5,040 | $1,659 | 32.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 21 | 22 | $2,860 | $636.94 | 22.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 267 | 335 | $445,550 | $166,124 | 37.3% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 85 | 106 | $132,288 | $51,026 | 38.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 65 | 91 | $73,437 | $29,510 | 40.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 72 | 85 | $80,580 | $16,054 | 19.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 41 | 48 | $41,184 | $9,520 | 23.1% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2022 | 47 | 47 | $36,707 | $7,272 | 19.8% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2022 | 22 | 22 | $18,700 | $3,728 | 19.9% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2022 | 26 | 27 | $16,605 | $3,133 | 18.9% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2022 | 11 | 12 | $9,624 | $2,391 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 34 | $6,120 | $2,345 | 38.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 16 | 16 | $9,728 | $2,177 | 22.4% |
About Dr. Lara Rosenbaum, M.D
Dr. Lara Rosenbaum, M.D is a MOHS-Micrographic Surgery healthcare provider based in Glendale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922360601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lara Rosenbaum, M.D has received a total of $2,351 in payments from pharmaceutical and medical device companies, with $416.94 received in 2024. These payments were reported across 84 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,351).
As a Medicare-enrolled provider, Rosenbaum has provided services to 2,770 Medicare beneficiaries, totaling 3,279 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Glendale, AZ
- Active Since 06/08/2012
- Last Updated 05/27/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1922360601
Products in Payments
- Otezla (Drug) $488.80
- SKYRIZI (Biological) $283.14
- TREMFYA (Drug) $207.32
- OPZELURA (Drug) $184.99
- RINVOQ (Biological) $167.68
- COSENTYX (Biological) $100.24
- HUMIRA (Biological) $93.78
- OLUMIANT (Drug) $92.20
- DUPIXENT (Biological) $66.79
- TALTZ (Drug) $63.10
- ILUMYA (Biological) $55.07
- Humira (Biological) $48.88
- Cimzia (Drug) $38.69
- Bimzelx (Biological) $34.73
- PICATO (Drug) $29.69
- VYJUVEK (Drug) $27.57
- SPEVIGO (Drug) $24.99
- LIBTAYO (Biological) $23.12
- BLU-U (Medical Supply) $22.71
- AMELUZ (Drug) $21.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.